Cathie's Ark Logo
Veracyte Inc Logo

ARKG Holdings of Veracyte (VCYT) - Updated Daily

BioinformaticsGenomics
Date
Direction
Shares
Fund Weight
Fund
September 20, 2022
BUY329.682k0.2318%ARKG
September 19, 2022
BUY20.446k0.014%ARKG
September 14, 2022
BUY117.290k0.0834%ARKG
September 13, 2022
BUY200.859k0.1349%ARKG
January 20, 2022
BUY26.000k0.0185%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
2.7%$1.93b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
13🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
21$18.52
🎫ARK Ownership Percent
2.94%
Description
veracyte is a pioneering genomic diagnostics company. our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. we ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. we are giving patients a clearer path forward. through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. we are making a difference in the lives of physicians and patients. we are doing something real. .
Website
veracyte.com

Other ETFs That Hold VCYT

Ticker
NameWeight
GNOMGlobal X Genomics & Biotechnology ETF2.88%
ARKGARK Genomic Revolution ETF2.65%
ARKKARK Innovation ETF1.49%
ARKWARK Next Generation Internet ETF1.46%
XBISPDR® S&P Biotech ETF0.88%
LABUS&P Biotech Bull 3X Shares ETF0.187%
IBBiShares Biotechnology ETF0.16%

Research Notes and Commentary for VCYT

No Research Notes Found for VCYT